Can results from clinical trials be generalized?

L Holmberg1, M Baum

  • 1Department of Surgery, University Hospital, Uppsala, Sweden.

Nature Medicine
|August 1, 1995
PubMed

Insights

Randomized clinical trials (RCTs) effectively challenge existing medical beliefs and introduce novel treatments. Their broader implementation in contemporary healthcare is strongly advocated for improved patient outcomes.

Area of Science:

  • Clinical Medicine
  • Medical Research Methodology

Background:

  • Established medical practices often lack rigorous empirical validation.
  • Prejudices can impede the adoption of potentially beneficial therapies.

Purpose of the Study:

  • To advocate for the increased utilization of randomized clinical trials (RCTs) in modern medicine.
  • To highlight the role of RCTs in advancing therapeutic regimes and challenging outdated medical dogma.

Main Methods:

  • This study proposes a conceptual framework for the expanded application of RCTs.
  • It emphasizes the evidence-based approach inherent in trial design.

Main Results:

  • RCTs provide robust evidence to dismantle unfounded medical assumptions.
  • They facilitate the establishment and validation of new therapeutic strategies.

Conclusions:

  • Randomized clinical trials are essential for scientific progress in medicine.
  • Widespread adoption of RCTs is crucial for evidence-based clinical decision-making and improved patient care.

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
8.5K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
631
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
252
Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
231